Gianni Benzi Pharmacological Research Foundation. Key concepts and Course presentation



Similar documents
IBM Healthcare Home Care Monitoring

REPORT' Meeting Date: April 19,201 2 Audit Committee

Asset set Liability Management for

CARE QUALITY COMMISSION ESSENTIAL STANDARDS OF QUALITY AND SAFETY. Outcome 10 Regulation 11 Safety and Suitability of Premises

Job Description. Programme Leader & Subject Matter Expert

est with berkeley / uc berkeley exten xtension / be your best with berkele

A Project Management framework for Software Implementation Planning and Management

A Best Practices Symposium

Siemens IT Solutions and Services Pvt. Ltd.

WORKERS' COMPENSATION ANALYST, 1774 SENIOR WORKERS' COMPENSATION ANALYST, 1769

A n n u a l R e p o r t o f t h e A d o l e s c e n t S c h o o l H e a l t h P r o g r a m. c t i o n. Louisiana SBHC.

union scholars program APPLICATION DEADLINE: FEBRUARY 28 YOU CAN CHANGE THE WORLD... AND EARN MONEY FOR COLLEGE AT THE SAME TIME!

SCHOOLS' PPP : PROJECT MANAGEMENT

Non-Emergency Health Transport

The University of Bonn Internationally connected

Rural and Remote Broadband Access: Issues and Solutions in Australia

FACULTY SALARIES FALL NKU CUPA Data Compared To Published National Data

Presentation on Short-Term Certificates to the CAPSEE Conference. September 18, 2014

Cisco Data Virtualization

Resource Management and Audit Scrutiny Panel. Apologies for absence were received from Councillors Child, Gilchrist, Maginnis and O Donnell.

erkeley / uc berkeley extension Be YoUR Best / be est with berkeley / uc berkeley With BerkELEY exten xtension / be your best with berkele

Cost Benefit Analysis of the etir system Summary, limitations and recommendations

Gianni Benzi Pharmacological Research Foundation

EVALUATING EFFICIENCY OF SERVICE SUPPLY CHAIN USING DEA (CASE STUDY: AIR AGENCY)

education counselor education

2014 Long-Term and Post-Acute Care Health IT Summit

Independent Living News

From Access to Education, Health and Innovation

Contents. President s Statement. Chief Executive Officer s Review. The Role and Functions of the Medical Council. The Medical Council

Data warehouse on Manpower Employment for Decision Support System

ITIL & Service Predictability/Modeling Plexent

STUDENT. Achieve More! AT A GLANCE BECOME A CWI. I fee. Learn More: OPPORTUNITIES TO

European Journal of Business and Management ISSN (Paper) ISSN (Online) Vol 4, No.6, 2012

Create Change Create Change Design Forums Create Change Design Forums to register:

embedded e e in numbers, facts and figures

Product Overview. Version 1-12/14

Architecture of the proposed standard

BERKELEY CITY COLLEGE April 16, 2015 Curriculum Committee Meeting Agenda

Where design facilitates health to lead innovation

Why An Event App... Before You Start... Try A Few Apps... Event Management Features... Generate Revenue... Vendors & Questions to Ask...

Likeli Score Controls Gaps in control or action required Assurances Future actions. 3- Possibl e. Major. Major. management. Governance Manager

Remember you can apply online. It s quick and easy. Go to Title. Forename(s) Surname. Sex. Male Date of birth D

est with berkeley / uc berkeley exte xtension / be your best with berkel

RECORD-BREAKING PERFORMANCE BY SINGAPORE HOTELS IN 2012

Natural Gas & Electricity Prices

Maintain Your F5 Solution with Fast, Reliable Support

How To Fund A Farm In Colombia

M.1 Emergency Response Continuity of Operations Plan

Human Resources and Organisational Development Services. Service Area Name: Services to Schools Account Manager:

I would appreciate the opportunity to discuss your needs and how I can help you meet your goals.

Enterprise Resource Planning (ERP) Systems

Warsaw International Studies in Psychology WINTER 2012/2013 YEAR 5

YouthWorks Youth Works (yüth- w rkz), n.

GOAL SETTING AND PERSONAL MISSION STATEMENT

CDP Climate Change Report 2015

ITCS Information Technology Computing Services

School Improvement Plan. Community Ed. Resource Center

STATEMENT OF INSOLVENCY PRACTICE 3.2

Thursday, March 18, :07 PM Page 1 of 16

Stag and Capital Bids in Indian Scenario

Seeking opportunities for bigger impact: Climate Performance in the Benelux. CDP Benelux Climate Change Report 2014

Fleet vehicles opportunities for carbon management

Stop! Safety first November. New helix test: ideal process challenge device with indicators for the simulation of worst-case scenarios

Free ACA SOLUTION (IRS 1094&1095 Reporting)

ANDREAS MAHENDRO KUNCORO S.T., University of Gadjah Mada, 2004 M.S., University of Cincinnati, 2009 M.S., University of Central Florida, 2010

Use a high-level conceptual data model (ER Model). Identify objects of interest (entities) and relationships between these objects

Ministero della Salute

Econ 371: Answer Key for Problem Set 1 (Chapter 12-13)

l C a m p b N e w m a n CAmpbell Newman t r Q u t h First 100 days

Requirements Minor American Sign Language/Deaf Studies

Ethics of Pediatric Research

Gold versus stock investment: An econometric analysis

FOREIGN EXCHANGE RISK MANAGEMENT PRACTICES - A STUDY IN INDIAN SCENARIO

Annual Action Plan. City of Spokane. Community Development Block Grant (CDBG), HOME and Emergency Solutions Grant (ESG) Programs

pae Ziu$oany poe Luo!$eanpa 'SSJV Zujuis~~sad 'ssauisna isaxtaps pus spv) pa4eajd

Practical Embedded Systems Engineering Syllabus for Graduate Students with Multidisciplinary Backgrounds

5.3.2 APPROACH TO PERFORMANCE MANAGEMENT

Voice Biometrics: How does it work? Konstantin Simonchik

Development of Financial Management Reporting in MPLS

CDP Global Climate Change Report 2015

Information Management Strategy: Exploiting Big data and Advanced Analytics

This page is left blank intentionally.

a m e s y s AMESYS INTELLIGENCE SOLUTIONS C RITIC A L SYSTEM ARCHITEC T SERVICES PROVIDED C O N T A C T S

Media Considerations Related to Puerto Rico s Fiscal Situation

District Improvement Plan Plainwell Community Schools. Ms. Susan Wakefield, Superintendent 600 School Drive Plainwell, MI

Planning and Managing Copper Cable Maintenance through Cost- Benefit Modeling

Moving Securely Around Space: The Case of ESA

Universal, Family-based Substance Abuse Prevention for Youth

caitlin SIDE articulate back on her bike 3 10 Limb 5 Successful inspection 7 Travel scholarship 9 New equipment 12 Aye, Aye Captain Staff open day

NEWS. As we begin the New Year, we. A Critically Important Time for Medicine and Psychiatry John Gilmore, M.D., President. From the President...

June Enprise Rent. Enprise Author: Document Version: Product: Product Version: SAP Version:

content Fresh thinking for decision makers

Global Sourcing: lessons from lean companies to improve supply chain performances

National Shared Services Primary Care Reimbursement Service STATISTICAL ANALYSIS OF CLAIMS AND PAYMENTS 2005

Generic Assessment Rubrics for Computer Programming Courses

MISSION STATEMENT 01. The Maccorp Group was founded in Italy in 1990, opening its first bureau de change in Venice in 1991.

Systems medicine and integrated care for pulmonary rehabilitation. E.F.M. Wouters Department of Respiratory Medicine Maastricht University

Transcription:

Gianni Bnzi Pharmacological Rsarch Foundation Ky concpts and Cours prsntation Halthcar biotch is alrady bnfiting mor than 350 million patints around th world through th us of biotch mdicin to trat and prvnt vry day acut and chronic illnsss including hart attacks, strok, multipl sclrosis, brast cancr, cystic fibrosis, lukamia, diabts, hpatitis, tc (Byond bordrs, 2012). Nvrthlss, as strssd in th Europan Mdicins Agncy (EMA) Road Map to 2015, an important public-halth challng currntly facd is th lack of mdicins for unmt mdical nds. For xampl, today in Europ, dspit th vidnt nd, thr is still a dramatic lack of tratmnts for 30 million Europans affctd by any of th 5,000 to 7,000 rar disass. In addition, spcial population including ldrly and childrn hav fw thraputic options tailord for thir mdical unmt nds. This yar th annual Forsight Training Cours of th Gianni Bnzi Pharmacological Rsarch Foundation will tak its cu from th advancmnt in biotchnology to addrss patint nds and is dsignd around th following topics: Rol and Rlvanc of Biotchnology in th procss of Drug Innovation Biotchnology covring thraputic nds Rgulatory Controvrsis and Novltis Th Cours will b th occasion to discuss biotch rsults and challngs by diffrnt stakholdrs points of viw: in particular th Cours will focus on th promiss of th markt and th rlvanc of th partnring of small companis with Big Pharma, on th ffcts (risk and bnfits) of th ongoing rgulatory initiativs in th pharmacutical sctor, on patints xpctancis and, ovrall, on th acquird and on-going scintific rsults. THE COURSE IS ORGANISED IN THE CONTEXT OF THE: Th Cours will provid 22,2 Italian ECM crdits for Halthcar Profssionals, and will b hld in Bari, on th initiativ of th Gianni Bnzi Pharmacological Rsarch Foundation and th High-Tch District Biotchnology and Halth (H-BIO Puglia).

COURSE PROMOTERS Gianni Bnzi Pharmacological Rsarch Foundation Th Gianni Bnzi Pharmacological Rsarch Foundation is a rgistrd not-for-profit Scintific Rsarch Organisation, foundd on 9 Novmbr, 2007. Th mission is to contribut to th advancmnt of pharmacological rsarch in thos filds whr th scintific hritag of Prof Gianmartino Bnzi has bn mor prominnt thus focusing on Innovativ Mdicins, mdicins for rar or nglcting disass and mdicins for spcial populations including childrn. Whil supporting pharmacological rsarch, th Foundation is spcially committd to provid ducational support and to st up activitis in th Rgulatory Scinc sctor having as rfrnc th Europan dimnsion as th natural framwork to favoring innovation, to dfining common ruls and adquat procdurs, to nsuring quality of accss to fficacious and saf tools and mdicinals to all Europan citizns. Th Forsight Training Courss, annually organizd by th Gianni Bnzi Pharmacological Rsarch Foundation ar short courss for rsarchrs and xprts in th fild of Rgulatory Scincs that aim at contributing to satisfy th incrasing knowldg nds of th sctor. High-Tch District Biotchnology and Halth (H-BIO Puglia) H-Bio Puglia is a High Tchnology District in th fild of halth and biotchnology with th aim of nhancing innovation in th manufacturing systm in th Italian Rgion of Apulia. Th activitis will b implmntd by an important ntwork involving univrsitis, rsarch cntrs and biotch companis, with th intntion to rspond to fundamntal nds: on th on hand th nd of th citizns to safguard thir right to vr mor advancd and innovativ thrapis, and on th othr hand th nd of rsarch and dvlopmnt that try to mt this dmand. Th main aras of intrst of th District ar rprsntd by th dvlopmnt of prsonalisd mdicin (mainly basd on biomarkrs drivd by th DNA/RNA tchnologis), advancd thrapis (including gn thrapy, cllular and tissu thrapy), innovativ diagnostics (including drug discovry and drugs dlivry) and nw manufacturing procsss. Th High-Tch District H-BIO Puglia was stablishd as Consortium on Sptmbr 14th 2012 and involvs a total of 36 public and privat partnrs.

COURSE COORDINATORS Adriana Cci Gianni Bnzi Pharmacological Rsarch Foundation Prsidnt Maria Svlto H-BIO High Tchnology District Prsidnt COURSE SCIENTIFIC COMMITTEE Enrico Boson - SIAR, Italian Socity for Rgulatory Activitis (Italy) Vito Michl Fazio - IRCCS Ospdal Casa Sollivo dlla Soffrnza (Italy) Viviana Giannuzzi - Gianni Bnzi Pharmacological Rsarch Foundation (Italy) Mark Migdal - Childrn s Mmorial Halth Institut Warsaw (Poland) Vincnzo Salvator - Univrsity of Insubria (Italy) ORGANISING SECRETARIAT Gianni Bnzi Pharmacological Rsarch Foundation Via Abat Eustasio 30, 70010 Valnzano (BA) Italy - VAT: IT06780820723 - Taxpayr s cod: IT93347800729 - www. bnzifoundation.org Administrativ offic: Via Putignani 178, 70122 Bari Italy - Tl. +39 080 9751974 / fax +39 080 9727756 - scrtary@bnzifoundation.org Oprational offic: Tcnopolis, S.P. Casamassima Km 3-70010 Valnzano (BA) Italy - Tl. +39 080 4670430 / Tl.-Fax +39 080 4670281 - info@bnzifoundation.org for furthr information plas contact Bonka Gorgiva - bg@bnzifoundation.org or Rosy Piaggion - rp@bnzifoundation.org

3 0 S p t m b r 9,30 am WELCOME SESSION INSTITUTIONAL REPRESENTATIVES INTRODUCTORY SESSION Introduction of th Cours (A. Cci, Gianni Bnzi Foundation Prsidnt) Th H-BIO District: challngs and opportunitis (M. Svlto, H-Bio Puglia Prsidnt) Rgulatory Scinc rlvanc and Biotchnology (W. Bianchi, SIAR Prsidnt) Innovation in th Pharmacutical fild (A. G. Dl Santo, Farmindustria-Biotchnology Group) 11,00 am I SESSION Rol and Rlvanc of Biotchnology in th procss of Drug Innovation Chairs of th sssion: M. Svlto - A. Cci EATRIS, th Europan Infrastructur for translational rsarch in Europ (G. Migliaccio, EATRIS) Trnds in th Europan Biotchnology Markt (A. Irion, Ernst & Young) Innovativ Mdicins Initiativ, th largst public-privat initiativ to boost pharmacutical innovation in Europ (G. Rubrti, CNR) High Tchnology Districts and Clustrs in th national and intrnational framwork (F. Coniclla, Bioindustry Park) Big Pharma, SMEs and Acadmy collaboration to fostr Biotchnology innovation (M. L. Nolli, Assobiotc)

2,30 pm II SESSION Biotchnology to covr thraputic nds Chairs of th sssion: M. Saviano - S. Cotcchia Towards th Prsonalisd Mdicins: microrna targting Nuroblastoma (M. Saviano, CNR-Institut of Crystallography) Thraputic vaccins (D. Criscuolo, Gnovax) Stm clls us in childrn (B. Dmbowska-Baginska, COMP-EMA) 3 0 S p t m b r Gn thrapy in hamatological disordrs (S. Acuto, AOR Villa Sofia-Crvllo/P. Cutino Foundation) 4,30 pm III SESSION Biotchnology in oncology Chairs of th sssion: V. Fazio - G. Migliaccio Advancmnt in biotchnological rsarch in oncology (V. M. Fazio, IRCCS Ospdal Casa Sollivo dlla Soffrnza) Gnomic approach to discovr human cancr pathways (M.T. Landi, NIH USA) Cancr Stm Clls (A. Vscovi, IRCCS Ospdal Casa Sollivo dlla Soffrnza) Prognostic microrna/mrna signatur and prsonalisd mdicin (S. Volinia, Univrsity of Frrara) Biomarkrs and Companion Diagnostic Tsts in targtd Drug Dvlopmnt (Ann Mathiu-Bou, Novartis Oncology) Monoclonal Antibodis in cancr (M. Allgrtti, Dompè)

1 O c t o b r 9,00 am IV SESSION Innovation in Padiatrics and Thraputic Nds Chairs of th Sssion: A. Costscu - P. Rossi Th EU promots padiatric rsarch (A. Costscu, EU Commission) Translating rsarch in drugs dvlopmnt: th lsson from th EU fundd padiatric rsarch for drug dvlopmnt (A. Cci, Gianni Bnzi Foundation; PDCO-EMA) Exprincs from: NoMro - Europan multicntr ntwork to valuat PK, safty and fficacy of Mropnm in nonatal spsis and mningitis (I. Lutsar, Univrsity of Tartu, Estonia; PDCO-EMA) DEEP - DEfripron Evaluation in Padiatrics (D. Bonifazi, Consortium for Biological and Pharmacological Evaluation) 11,00 am V SESSION Padiatric Ntworks to improv rsarch Chairs of th sssion: M. Migdal - V. Giannuzzi Th Padiatric Ntworks improving padiatric rsarch (C. Giaquinto, GRiP Ntwork Coordinator, TEDDY Ntwork Co-Coordinator) InNrMD-I-Ntwork - Inhritd NuRoMtabolic Disass Information Ntwork (F. Bonifazi, Gianni Bnzi Foundation) Padiatric Nds ar w going th right dirction? (A. Nubrt, Univrsity Hospital Erlangn) Padiatric trials: how to dal with th missing data? (M. Catapano, Italian Group for Pharmacoconomic Studis) How to involv childrn in th rgulatory dcisions (E. Davis, Elin Haf Davis Enabling Rsarch, Empowring Childrn)

2,30 pm VI SESSION Biotchnology and coagulopathis Chairs of th sssion: P. Giordano - F. Houyz Rcnt progrss in th fild of inhritd coagulopathis (P. Giordano, Univrsity Bari Aldo Moro ) Advancs in hamophilia (P. Mathw, Bayr HalthCar) 1 O c t o b r Nw trnds in childrn anticoagulation (A. C. Molinari, IRCCS G. Gaslini) Expanding th Boundaris of Hamophilia Car: nw drugs in dvlopmnt (S. Srmtis, Novo Nordisk) 4,30 pm VII SESSION Agd popl and thraputic Innovation Chairs of th Sssion: M. Scatigna - R. Brnabi Thraputic nds in aging : th EMA griatric mdicins stratgy (N. Marchionni, EMA GEG, Univrsity of Firnz) Th CHMP rol for a sustainabl drug dvlopmnt for old popl (A. Gyurasics, CHMP-PDCO - tbc) Ongoing pharmacological rsarch and xpctd rsults (A. Gnazzani, Univrsity Pimont Orintal ) Unmt nds and thraputic Innovation in Alzhimr disas (V. Lpor, Univrsity of Bari Aldo Moro )

2 O c t o b r 9,00 am VIII SESSION Outstanding rgulatory and lgislativ issus -1 Chairs of th Sssion: V. Salvator - A. Natz How to dal with rgulatory controvrsis: th V Forsight Cours Lsson (E. Boson, Clgn) GCP and Pharmacovigilanc: a challng for Biotch studis and Rsarch (A. Dl Vcchio, AIFA) Th nw Rgulation on Clinical Trials (A. Altavilla, Espac Ethiqu Méditrranén) A padiatric updat: th 5-yar rport and th public consultation (M. Migdal, PDCO- EMA) Clinical Trials: th Transparncy of rsults and th accss to data (V. Salvator, Univrsity of Insubria) 11,30 am IX SESSION Outstanding rgulatory and lgislativ issus -2 Chairs of th Sssion: G. Banfi - A. Dl Vcchio Pric Rgulation in Europ (A. Natz, EUCOPE) Rgulation on Privacy and Data Protction (G. Buttarlli, EDPS) Exprts without conflict of intrst: an incrasing problm? (A. Cislik, Polish NCA) Mdicin supply shortags (F. Houyz, EURORDIS) Partnrships in biotchnology: what Big Pharmas want th vaccin prospctiv (L. Tollri, Novartis Vaccins and Diagnostics) Closing Rmarks 2,30 pm

LIST OF CHAIRS AND SPEAKERS Santina Acuto AOR Villa Sofia-Crvllo/P. Cutino Foundation (Italy) Marcllo Allgrtti Dompé, Rsarch and Dvlopmnt Dirctor (Italy) Annagrazia Altavilla Espac Ethiqu Méditrranén - Aix-Marsill Univrsity, Associat Snior Lcturr of Biotics (Franc) Giuspp Banfi Scintific Dirctor Galazzi Milan, Gnral Dirctor of th Cntro San Raffal Foundation (Italy) Robrto Brnabi Univrsity Cattolica dl Sacro Cuor, Profssor of Intrnal Mdicin; Univrsity Hospital A. Gmlli, Dpartmnt of Griatrics and Rhabilitativ Mdicin, Dirctor; Board Mmbr of th Europan Acadmy for Mdicin of Aging (EAMA). Waltr Bianchi Prsidnt of SIAR; Mmbr of th Gianni Bnzi Foundation s Board of Dirctors (Italy) Donato Bonifazi Consortium for Biological and Pharmacological Evaluations, Managing Dirctor; DEEP Projct Managr (Italy) Fdl Bonifazi Gianni Bnzi Pharmacological Rsarch Foundation, Vic Prsidnt; InNrMD-I-Ntwork, Projct Managr (Italy) Enrico Boson SIAR Board of Dirctors Rprsntativ (Italy) Giovanni Buttarlli Europan Data Protction Suprvisor (EDPS) (Blgium) Mariana Catapano Italian Group for Pharmacoconomics Studis, Dirctor (Italy) Adriana Cci Gianni Bnzi Pharmacological Rsarch Foundation, Prsidnt (Italy); Europan Mdicins Agncy (EMA), Mmbr of PDCO Anna Cislik Offic for Rgistration of Mdicinal Products, Mdical Dvics and Biocidal Products, Dirctor of Dpartmnt of Assssmnt of Mdicinal Products Documntation (Poland) Fabrizio Coniclla Bioindustry Park Silvano Fumro SpA, Dirctor Businss Dvlopmnt and intrnational projct; Coordinator at th biopmd Innovation Clustr (Italy) Alxandru Sorin Costscu EU Commission Susanna Cotcchia Univrsity of Bari Aldo Moro, Profssor of Pharmacology; Consortium for Biological and Pharmacological Evaluations, Prsidnt (Italy) Domnico Criscuolo Gnovax S.r.l., Chif Excutiv Officr (Italy) Elin Haf Davis Elin Haf Davis Enabling Rsarch - Empowring Childrn, Dirctor (UK) Antonio Giuspp Dl Santo Farmindustria-Biotchnology Group (Italy) Angla Dl Vcchio Italian Mdicins Agncy (AIFA), Dirctor Good Clinical Practic and Pharmacovigilanc Inspctorat (Italy) Boznna Dmbowska-Baginska Th Childrn s Mmorial Halth Institut, Vic Chair, Profssor at Th Dpartmnt of Pdiatric Oncology; Europan Mdicins Agncy (EMA), Mmbr of COMP (Poland) Vito Michl Fazio Spcialist in Oncology; Univrsity Campus Bio- Mdico, Ara of Gnral Pathology, Chairman (Italy) Armando Gnazzani Univrsity Pimont Orintal, Profssor of Pharmacology (Italy) Viviana Giannuzzi Gianni Bnzi Pharmacological Rsarch Foundation, Had of thics and ducation unit (Italy) Carlo Giaquinto GRIP and PENTA Ntworks Coordinator Paola Giordano U.O. Pdiatria F. Vcchio - Univrsity Hospital, Policlinic of Bari (Italy) Agns Gyurasics Europan Mdicins Agncy (EMA), Mmbr of PDCO and CHMP; National Institut of Pharmacy, Chif Advisor to th Gnral Dirctor (Hungary)

LIST OF CHAIRS AND SPEAKERS Francois Houyz Europan Rar Disass Organisation (EURORDIS), Halth Policy Dirctor (Franc) Antonio Irion Ernst&Younng, Advisory Lif Scinc Ladr Maria Trsa Landi National instituts of Halth (NIH), Gntic Epidmiology Branch Division of Cancr Epidmiology and Gntics National Cancr Institut, Snior Invstigator (USA) Vito Lpor Consorzio Mario Ngri Sud, Dpartmnt of Clinical Pharmacology and Epidmiology, Laboratory of Epidmiology of Dlivrd Car and Informatics Systms, Had (Italy) Irja Lutsar Profssor of Mdical Microbiology, Univrsity of Tartu (Estonia); Europan Mdicins Agncy (EMA), Mmbr of PDCO Niccolò Marchionni Univrsity of Firnz, Profssor of Grontology and Griatrics; EMA GEG Chair (Italy) Prasad Mathw Vic Prsidnt, Global Mdical affairs - Hmatology, Bayr Halth Car; Profssor of Pdiatrics, Pdiatric Hmatology/Oncology Univrsity of Nw Mxico (USA) Ann Mathiu-Bou Novartis Oncology, Rgion Europ, Mdical Affairs, Snior Mdical Dirctor, Pi3 Kinas Inhibitors Mark Migdal Europan Mdicin Agncy (EMA), Mmbr of PDCO; Childrn s Mmorial Halth Institut, Dputy Had, PICU, Had of Long Trm Car Unit (Poland) Giovanni Migliaccio Europan Advancd Translational Rsarch Infrastructur in Mdicin (EATRIS), Scintific Dirctor (Th Nthrlands); Italian Institut of Halth (ISS), Had of th Gn and Cll Thrapy Sction (Italy) Anglo Claudio Molinari Giannina Gaslini Childrn s Hospital, Thrombosis and Hmostasis Unit and Hmophilia Trating Cntr, Dirctor (Italy) Alxandr Natz Europan Confdration of Pharmacutical Entrprnurs (EUCOPE), Scrtary-Gnral Antj Nubrt Univrsity Hospital Erlangn, Dpartmnt of Padiatric and Adolscnts Mdicin, Had Padiatric Clinical Study Cntr (Grmany) Maria Luisa Nolli Assobiotc, Mmbr of th Excutiv Committ; Mmbr of th EuropaBio Board; Arta Intrnational, Foundr and Chif Excutiv Officr (Italy) Paolo Rossi Childrn s Hospital Bambino Gsù, Dpartmnt of Padiatrics, Chairman (Italy); Europan Mdicin Agncy (EMA), Mmbr of PDCO Giovina Rubrti National Rsarch Council (CNR), Rsarch Dirctor, Institut of Cll Biology and Nurobiology MIUR Dlgat IMI-JU Vincnzo Salvator Univrsity of Insubria Vars, Profssor of Intrnational Law (Italy) Michl Saviano Dirctor Institut of Crystallography (IC)-CNR, Prsidnt of Italian Crystallographic Association (AIC) (Italy) Marco Scatigna Sanofi-Avntis, Mdical and Scintific Dirctor, Gnral Managr S. A. Foundation (Italy) Stphani Valri Srmtis Novo Nordisk, Corporat Vic Prsidnt and Chif Mdical Officr Hmophilia R&D Portfolio (USA) Vittorio Silano Univrsity of Rom II; Chair ESCO Working Group, EFSA Europan Food Safty Authority; Chair of th Gianni Bnzi Foundation s Scintific Committ Maria Svlto High Tchnology District H-Bio Puglia, Prsidnt (Italy) Lornzo Tollri Novartis Vacinis and Diagnostics, Businss Dvlopmnt Snior Managr (Italy) Anglo Luigi Vscovi IRCCS Casa Sollivo dlla Soffrnza, Scintific Dirctor (Italy) Stfano Volinia Univrsity of Frrara, Dpartmnt of Morphology and Embryology (Italy)

HOW TO REACH BARI By plan Thr ar dirct flights from Bari to: BARCELLONA, BOLOGNA, BRUSSELS CHARLEROI, BUCAREST, BUDAPEST, CAGLIARI, CATANIA, CLUJ, DUSSELDORF WEEZE FRANKFURT HAHN, GENOVA, IBIZA, KARLSRUHE-BADEN, LONDON GATWICK, LONDON STANSTED, LUXEMBOURG, MAASTRICHT, MALTA, MIKONOS, MILANO LINATE, MILANO MALPENSA, MILANO-BERGAMO, MUNICH, MOSCHOW DME, MOSTAR, PALERMO, MAIORCA, PARIS PARIS BEAUVAIS, PISA, PRAGUE, RIGA, ROMA CIAMPINO, ROMA FIUMICINO, SANTORINI, SEVILLE, STUTTGART, TIRANA, TORINO, TRIESTE, VALENCIA, WARSAW CHOPIN, WARSAW MODLIN, VENEZIA, VENEZIA-TREVISO, VERONA, ZURIGO. COURSE LOCATION VILLA ROMANAZZI CARDUCCI Via Capruzzi 326-70124 Bari - Italy Tl.: +39 080 5575265 prnotazioni@villaromanazzi.com http://www.villaromanazzi.it/